Segment & Geographic Data Quant-Grade Normalized (live API) API & CSV Delivery

Biomerica Inc's Business Segments

Biomerica Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.

Segment Data As of FY
Reportable Segments
1
Per the company's own filing, this quarter
Largest Segment
Clinical Lab
Total Revenue
$ 1
Consolidated, this quarter
Regions Reported
5
Geographic regions, this quarter
API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/BMRA/segments
https://api.csimarket.com/api/v1/companies/BMRA/geographic
https://api.csimarket.com/api/v1/companies/BMRA/exposure
Programmatic access for models, analytics, and integration workflows.
Dataset & schema
https://api.csimarket.com/api/datasets/business_segments
https://api.csimarket.com/api/schema/business_segments
https://api.csimarket.com/api/meta/business_segments

Revenue Share by Reportable Segment - FY

0%largest
  • Clinical Lab0%

Revenue by Reportable Segment - FY

SegmentPeriodRevenue
(Millions)
% of TotalOperating Income
Clinical LabFY$ 1--

Revenue Share by Region - FY

29%largest
  • Europe29.1%
  • Asia27.4%
  • North America26.2%
  • Middle East17.3%
  • South America0%

Revenue by Geographic Region - FY

RegionPeriodRevenue
(Millions)
% of Total
EuropeFY$ 029.1%
AsiaFY$ 027.4%
North AmericaFY$ 026.2%
2 more regions available

Sign in to unlock the full Biomerica Inc dataset.

Revenue by Product & Service Category - FY

63%largest
  • Clinical Lab62.9%
  • Over The Counte20%
  • Contract Manufacturing16.9%
  • Physicians Office0.2%

Revenue by Product & Service Category - FY

CategoryPeriodRevenue
(Millions)
% of Total
Clinical LabFY$ 162.9%
Over The CounteFY$ 020%
Contract ManufacturingFY$ 016.9%

Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.

1 more categories available

Sign in to unlock the full Biomerica Inc dataset.

Annual Results

Revenue Share by Reportable Segment - FY

0%largest
  • Clinical Lab0%

Revenue by Reportable Segment - FY

SegmentPeriodRevenue
(Millions)
% of TotalOperating Income
Clinical LabFY$ 1--

Description of Biomerica Inc

Biomerica Inc. is a global biotechnology company that specializes in creating advanced diagnostics and testing solutions. Established in 1971, the company is headquartered in Irvine, California, USA.

Biomerica's primary focus is on developing and manufacturing products that facilitate early detection and monitoring of various medical conditions. The company's core competencies lie in the fields of immunology, hematology, and molecular diagnostics. Biomerica's innovative testing solutions are designed to improve patient outcomes by providing accurate and rapid results.

One of Biomerica's notable product lines is the InFoods™ technology, which is a patented diagnostic-guided therapy for gastrointestinal disorders, including Irritable Bowel Syndrome (IBS). InFoods™ helps identify food-related factors causing gut problems, allowing personalized dietary recommendations for patients to effectively manage their symptoms.

In addition to InFoods™, Biomerica has a diverse portfolio of diagnostics products catering to different medical conditions. These include tests for celiac disease, colorectal cancer screening, diabetes monitoring, and infectious diseases detection. Biomerica's products are sold both domestically and internationally through a combination of direct sales, distributor partnerships, and licensing agreements.

The company's manufacturing facilities are compliant with Good Manufacturing Practices (GMP) and are subject to rigorous quality control standards. Biomerica prioritizes product quality and safety throughout the manufacturing process, ensuring the reliability of their diagnostic tools.

Biomerica possesses a strong research and development (R&D) team dedicated to driving innovation in the field of diagnostics. The company invests in cutting-edge technologies and collaborations with leading academic institutions and research organizations to fuel the development of novel diagnostic solutions.

Additionally, Biomerica emphasizes regulatory compliance, obtaining necessary certifications and approvals to market and sell its products globally. The company is registered with the U.S. Food and Drug Administration (FDA) and holds various international certifications, including ISO 13485:2016.

As a socially responsible organization, Biomerica actively contributes to improving global health outcomes. The company's mission is to develop and provide affordable diagnostic tools that enhance patient care, reduce healthcare costs, and empower individuals to manage their health effectively.

Overall, Biomerica Inc. is a prominent biotechnology company known for its advanced diagnostics and testing solutions. With a dedication to innovation, quality, and improving patient outcomes, Biomerica continues to make significant contributions to the field of healthcare.
Biomerica Inc. is a biomedical company that specializes in developing and manufacturing innovative diagnostic solutions, primarily focused on gastrointestinal and autoimmune diseases. Below is a detailed overview of the segments, products, and services that Biomerica offers, based on the known offerings in the industry.

Segments

1. Diagnostics: The core segment of Biomerica’s business revolves around developing diagnostic products. These products are designed to detect various health conditions through simple and reliable test methods.

2. Research and Development: This segment emphasizes innovation and the creation of new diagnostic technologies and products. The R&D team focuses on advancing techniques for improved accuracy and ease of use in clinical settings.

3. Manufacturing: Biomerica produces a variety of diagnostic test kits in compliance with strict quality standards. This segment includes both the production of proprietary products and the potential for contract manufacturing services.

Products

1. Diagnostic Test Kits: Biomerica offers a range of test kits that cover a variety of medical conditions.
- Gastrointestinal Testing: These kits are designed to diagnose conditions such as lactose intolerance, H. pylori infections, and other gastrointestinal disorders. They often use stool or breath tests for ease of use in home or clinical environments.
- Autoimmune Disease Testing: The company provides test kits aimed at identifying markers for autoimmune diseases, including conditions like rheumatoid arthritis and celiac disease. These tests help in the early diagnosis and management of these diseases.

2. Point-of-care Testing Products: These are designed for use in clinical settings, allowing healthcare providers to conduct tests and receive results quickly, often within minutes. These products cater to a variety of diseases and can be pivotal in emergency care scenarios.

3. Food Intolerance Tests: Biomerica has developed tests for food intolerances, which help individuals identify specific food sensitivities that may be contributing to their health issues.

4. Laboratory Services: Biomerica may offer additional laboratory services related to their diagnostic products, which could include processing samples and providing expert analysis of test results.

5. Research Products: This includes products intended for use in research settings, such as reagents and assays used in clinical studies to help discover better diagnostic methods or treatments.

Services

1. Customer Support and Education: Biomerica offers extensive customer support to help healthcare practitioners and patients understand its products. This may include training, troubleshooting, and technical assistance.

2. Regulatory Compliance Consultation: Given the nature of their products, Biomerica may offer services to help facilitate compliance with health regulations and standards, ensuring that their products meet industry requirements.

3. Contract Manufacturing: If applicable, Biomerica might provide contract manufacturing services to third-party companies looking to produce their own diagnostic assays or kits.

4. Scientific Collaboration: The firm may engage in partnerships with research institutions or clinical labs to develop new testing methodologies or refine existing products, thereby contributing to the broader scientific community.

Conclusion

Biomerica Inc. focuses on delivering innovative diagnostic solutions that are both easy to use and reliable. Through a combination of various segments, products, and services, the company aims to provide effective tools for diagnosing a range of health issues, enhancing patient care, and supporting healthcare professionals in their treatment efforts. The ongoing commitment to research and development further positions Biomerica as a proactive player in the biomedical landscape, continually introducing novel solutions to meet emerging healthcare needs.
Get the full CSIMarket dataset: Subscribe API License